Clinical Trials in California

Showing 10861-10880 of 11,359 trials

MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma

NCT00298467

This study is an open-label, fixed-dose, multicenter study of MDX-060 in patients with ALCL who have relapsed or refractory disease. There will be 3 phases of this study: Induction, Maintenance, and Follow-up. Patients will be required to attend all protocol-required visits in the 4-week Induction Phase, in which administration of MDX-060 will occur, as well as other testing. Patients who complete the Induction Phase may be eligible for additional MDX-060 treatment ever 2 months for 1 year in the Maintenance Phase. Patients who complete the Maintenance Phase with a response of stable disease or better will be followed every 2 months for 1 year or until disease progression. The purpose of this study is to determine objective response rate at Day 50 in patients with relapsed or refractory classic systemic ALCL or primary cutaneous ALCL treated with MDX-060. Other objectives will be evaluated.

Lymphoma, Large-Cell

Bristol-Myers Squibb45 participantsStarted Feb 2006

Duarte, California, United States • Fresno, California, United States • La Jolla, California, United States +5 more locations

TERMINATED44 miles

3DKnee™ System vs. the MJS Knee System

NCT00764803

The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data collection is already under way.

Rheumatoid ArthritisTraumatic ArthritisJoint Disease Secondary to Osteoarthritis

Encore Medical, L.P.27 participantsStarted Jan 2008

Fresno, California, United States

MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma

3DKnee™ System vs. the MJS Knee System

Find Trials by Condition in California

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

A Trial of Skin Care Protocols for Facial Resurfacing

Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

Escitalopram in Adult Patients With Major Depressive Disorder

The LIFE Study: Lifestyle Interventions and Independence for Elders, Pilot

Long-term Data Collection for Subjects in MDX-010 Studies

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

Herpetic Eye Disease Study (HEDS) II

Complications of Age-Related Macular Degeneration Prevention Trial

CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

Preventing Pressure Ulcers in Veterans With Spinal Cord Injury (SCI)

Pilot Study Assessing the Feasibility of Treating Foot Drop With the Neurostep™ System.